Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Nature Biotechnology
|
December 13, 2016
Influence of donor age on induced pluripotent stem cells
Valentina Lo Sardo, William Ferguson, Galina A Erikson, et al.
Journal of Traumatic Stress
|
September 1, 2016
Association of Posttraumatic Growth and Illness-Related Burden With Psychosocial Factors of Patient, Family, and Provider in Pediatric Cancer Survivors
J Zachary Wilson, Donna Marin, Katherine Maxwell, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 7, 2017
Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension
Jack Ishak, Michael Rael, Henry Punzi, et al.
Current Neurovascular Research
|
September 27, 2005
Amyloid beta peptide 1-40 stimulates the Na+/Ca2+ exchange activity of SNCX
Menjor Tino Unlap, Corey Williams, Darryl Morin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial
Allen M Goorin, Michael B Harris, Mark Bernstein, et al.
Pediatric Blood & Cancer
|
August 4, 2015
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma
Deanna Mitchell, Genevieve Bergendahl, William Ferguson, et al.
Cell
|
December 12, 2018
Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing
Valentina Lo Sardo, Pavel Chubukov, William Ferguson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2022
A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma
Giselle Saulnier-Sholler, Dan G Duda, Genevieve Bergendahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2023
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons
Javier Oesterheld, William Ferguson, Jacqueline M Kraveka, et al.
International Journal of Cancer
|
May 12, 2020
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
Elizabeth C Lewis, Jacqueline M Kraveka, William Ferguson, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Nature Biotechnology
|
December 13, 2016
Influence of donor age on induced pluripotent stem cells
Valentina Lo Sardo, William Ferguson, Galina A Erikson, et al.
Journal of Traumatic Stress
|
September 1, 2016
Association of Posttraumatic Growth and Illness-Related Burden With Psychosocial Factors of Patient, Family, and Provider in Pediatric Cancer Survivors
J Zachary Wilson, Donna Marin, Katherine Maxwell, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 7, 2017
Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension
Jack Ishak, Michael Rael, Henry Punzi, et al.
Current Neurovascular Research
|
September 27, 2005
Amyloid beta peptide 1-40 stimulates the Na+/Ca2+ exchange activity of SNCX
Menjor Tino Unlap, Corey Williams, Darryl Morin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial
Allen M Goorin, Michael B Harris, Mark Bernstein, et al.
Pediatric Blood & Cancer
|
August 4, 2015
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma
Deanna Mitchell, Genevieve Bergendahl, William Ferguson, et al.
Cell
|
December 12, 2018
Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing
Valentina Lo Sardo, Pavel Chubukov, William Ferguson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2022
A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma
Giselle Saulnier-Sholler, Dan G Duda, Genevieve Bergendahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2023
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons
Javier Oesterheld, William Ferguson, Jacqueline M Kraveka, et al.
International Journal of Cancer
|
May 12, 2020
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
Elizabeth C Lewis, Jacqueline M Kraveka, William Ferguson, et al.
Page
of 4